2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure
A Report of the ACC/AHA Joint Committee on Performance Measures
Published 8 August 2024
Michelle M. Kittleson, MD, PhD, FACC, FAHA, FHFSA, Chair; Khadijah Breathett, MD, MS, FACC, FAHA, FHFSA; Boback Ziaeian, MD, PhD, FACC, FAHA, JCPM Liaison*; David Aguilar, MD, MSc, FAHA; Vanessa Blumer, MD; Biykem Bozkurt, MD, PhD, FACC, FAHA, FHFSA; Rebecca L. Diekemper, MPH; Michael P. Dorsch, PharmD, MS, FACC, FAHA; Paul A. Heidenreich, MD, MS, FACC, FAHA; Corrine Y. Jurgens, PhD, RN, ANP, FAHA, FHFSA§; Prateeti Khazanie, MD, MPH, FAHA; George Augustine Koromia, MD, MMCi, FACC; Harriette G.C. Van Spall, MD, MPH
This document describes performance measures for heart failure and is meant to serve as a focused update of the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Measure sets developed by the ACC/AHA are intended to provide practitioners and institutions that deliver cardiovascular services with tools to measure the quality of care provided and identify opportunities for improvement.
Writing committees are instructed to consider the methodology of performance measure development and to ensure that the measures developed are aligned with ACC/AHA clinical practice guidelines. The writing committees are also charged with constructing measures that maximally capture important aspects of care quality, including timeliness, safety, effectiveness, efficiency, equity, and patient-centeredness, while minimizing, when possible, the reporting burden imposed on hospitals, practices, and practitioners
The International Society for Heart and Lung Transplantation (ISHLT) endorsed this document in 2024.
Read at CirculationTop 10 Take-Home Messages for Adults with Heart Failure
- This document describes performance measures for heart failure that are appropriate for public reporting or pay-for-performance programs (ie, a form of value-based purchasing).
- The performance measures are taken from the “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines” and are selected from the strongest recommendations (Class 1 or 3).
- Quality measures are also provided that are not yet ready for public reporting or pay-for-performance but might be useful to clinicians and health care organizations for quality improvement.
Related Guidlines
-
Nursing, Health Sciences and Allied Health Core Competency Curriculum
-
Report from a Consensus Conference on Primary Graft Dysfunction after Cardiac Transplantation
-
2019 Updated Consensus Statement on the Diagnosis and Treatment of Pediatric Pulmonary Hypertension
-
Destination Mechanical Circulatory Support: Proposal for Clinical Standards
-
A 2010 Working Formulation for the Standardization of Definitions of Infections in Cardiothoracic Transplant Recipients